In glioma, ATRX/IDH/p53 combined mutations and individual mutations exhibit opposite effects on the immune microenvironment, which encourages tumor proliferation and invasion (Hu et al., 2022; Hariharan et al., 2024). This evidence concerns the gene TP53 and neoplasm.